Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  FEBS Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2365091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection.

  1990cited by this paper
• Complete characterization of the gene coding for the Epstein-Barr virus major membrane antigen gp 220/340 and selective expression of a secreted form of gp 220.

  1989cited by this paper
• Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.

  1989cited by this paper
• Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.

  1989cited by this paper
• Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen.

  1989cited by this paper
• Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector

  1987cited by this paper
• Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo.

  1987cited by this paper
• Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.

  1987cited by this paper
• Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector.

  1987cited by this paper
• Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin.

  1987cited by this paper
• A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids.

  1985cited by this paper
• Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis.

  1985cited by this paper
• High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli.

  1984cited by this paper
• Structure and variation of human α1–antitrypsin

  1982cited by this paper
• Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

  1977cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Construction and application of adenoviral vectors

  2023cites this paper
• My Pathway to Gene Therapy

  2020cites this paper
• Rapid generation of fowl adenovirus 9 vectors.

  2015cites this paper
• Respective roles of TNF-α and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice

  2007cites this paper
• Recombinant adenovirus vector-mediated functional expression of neurotropin-3 receptor (TrkC) in neural stem cells.

  2007cites this paper
• Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

  2003cites this paper
• Infection of cells with replication deficient adenovirus induces cell cycle alterations and leads to downregulation of E2F-1.

  2002cites this paper
• Secretion of Antithrombin Is Converted from Nonpolarized to Apical by Exchanging Its Amino Terminus for That of Apically Secreted Family Members*

  2002cites this paper
• Approaches for generating recombinant adenovirus vectors.

  2001cites this paper
• Les inhibiteurs d’élastases

  2001cites this paper
• Efficient Transformation of Primary Human Amniocytes by E1 Functions of Ad5: Generation of New Cell Lines for Adenoviral Vector Production

  2000cites this paper
• Apical and non‐polarized secretion of serpins from MDCK cells

  2000cites this paper
• The role of IL‐6 in the inflammatory and humoral response to adenoviral vectors

  2000cites this paper
• Polarized Secretion of Transgene Products from Salivary Glands in Vivo

  1999cites this paper
• Efficient Construction of a Recombinant Adenovirus Vector by an Improved In Vitro Ligation Method

  1998cites this paper
• Efficient Construction of a Recombinant Adenovirus Vector by an Improved In Vitro Ligation Method

  1998cites this paper
• Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance

  1998cites this paper
• Efficient, Repeated Adenovirus-Mediated Gene Transfer in Mice Lacking both Tumor Necrosis Factor Alpha and Lymphotoxin α

  1998cites this paper
• Efficient Construction of a Recombinant Adenovirus Vector by an Improved In Vitro Ligation Method

  1998cites this paper
• Adenovirus-mediated gene transfer of a human IL-6 antagonist

  1997cites this paper
• Use of the Cosmid Adenoviral Vector Cloning System for the In Vitro Construction of Recombinant Adenoviral Vectors

  1997cites this paper
• Phenotypic correction of dwarfism by constitutive expression of growth hormone.

  1996cites this paper
• Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging.

  1996cites this paper
• [Gene therapy for alpha 1-antitrypsin deficiency. Hopes, realities and perspectives].

  1996cites this paper
• Evidence for the Systemic Delivery of a Transgene Product from Salivary Glands

  1996cites this paper
• Immediate Inflammatory Responses to Adenovirus-Mediated Gene Transfer in Rat Salivary Glands

  1996cites this paper
• Strategies for cancer gene therapy using adenoviral vectors

  1996cites this paper
• Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.

  1995cites this paper
• Myoblast transfer and gene therapy in muscular dystrophies

  1995cites this paper
• Gene therapy using adenovirus vectors.

  1995cites this paper
• Therapeutic serum concentrations of human alpha‐1‐antitrypsin after adenoviral‐mediated gene transfer into mouse hepatocytes

  1995cites this paper
• Gene therapy for phenylketonuria

  1994cites this paper
• Adenovirus‐Mediated in Vivo Gene Transfer

  1994cites this paper
• Direct In Vivo Gene Transfer and Expression in Malignant Cells Using Adenovirus Vectors

  1994cites this paper
• Direct in vivo adenovirus-mediated gene transfer to salivary glands.

  1994cites this paper
• A Database of Recombinant Wild-type and Mutant Serpins

  1994cites this paper
• Gene Therapy and Endothelial Cell Targeting for Cancer

  1994cites this paper
• The use of DNA viruses as vectors for gene therapy.

  1994cites this paper
• Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy

  1993cites this paper
• Packaging capacity and stability of human adenovirus type 5 vectors

  1993cites this paper
• Hepatic gene therapy: Present and future

  1993cites this paper
• Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.

  1993cites this paper
• Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells.

  1992cites this paper
• Feasibility of adenovirus-mediated gene transfer in vivo.

  1992cites this paper
• Adenovirus–mediated in vivo gene transfer and expression in normal rat liver

  1992cites this paper
• Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo.

  1991cites this paper
• Method for rapid evaluation of topically applied agents to cystic fibrosis airways.

  1991cites this paper
• Expression of active recombinant human alpha 1-antitrypsin in transgenic rabbits.

  1991cites this paper